SEC Company Response from GT Biopharma, Inc. (GTBP) (CIK 0000109657) (GTBP) — Feb 9, 2007

GT Biopharma, Inc. (GTBP) (CIK 0000109657)
Date: Feb. 9, 2007 · CIK: 0000109657 · Accession: 0001144204-07-006113

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-139216

Date

Feb. 9, 2007

Author

Marvin S. Hausman

Form

CORRESP

Company

GT Biopharma, Inc. (GTBP) (CIK 0000109657)

Letter

Securities and Exchange Commission Division of Corporate Finance RE: OXIS International, Inc. Form SB-2 Registration Statement (File No. 333-139216)

Dear Ms. Fraser:

OXIS International, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (“Commission”) take appropriate action to make the above-captioned registration statement be ordered effective at 10:00 a.m. (E.S.T.) on February 12, 2007.

The Company acknowledges that:

1. should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

2. the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

3. the Company may not assert staff comments and the declaration of effectiveness as defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Very
truly yours,
/s/
Marvin S. Hausman

Show Raw Text

CORRESP
1
filename1.htm

      Unassociated Document

    February
      9, 2007

    Filed
      as Correspondence Via EDGAR

    Securities
      and Exchange Commission

    Division
      of Corporate Finance

    100
      F.
      Street, N.E.

    Washington,
      D.C. 20549

    Attn:
      Mary Fraser, Esq.

            RE:

              OXIS
                International, Inc.

    Form
      SB-2 Registration Statement

    (File
      No. 333-139216)

    Dear
      Ms.
      Fraser:

    OXIS
      International, Inc. (the “Company”) hereby requests that the Securities and
      Exchange Commission (“Commission”) take appropriate action to make the
      above-captioned registration statement be ordered effective at 10:00 a.m.
      (E.S.T.) on February 12, 2007.

    The
      Company acknowledges that:

    1. should
      the Commission or the staff, acting pursuant to delegated authority, declare
      the
      filing effective, it does not foreclose the Commission from taking any action
      with respect to the filing;

    2. the
      action of the Commission or the staff, acting pursuant to delegated authority,
      in declaring the filing effective, does not relieve the Company from its full
      responsibility for the adequacy and accuracy of the disclosure in the filing;
      and

    3. the
      Company may not assert staff comments and the declaration of effectiveness
      as
      defense in any proceeding initiated by the Commission or any person under the
      federal securities laws of the United States.

              Very
                truly yours,

              /s/
                Marvin S. Hausman

              CEO,
                OXIS International, Inc.

    cc:
       Edgar
      D.
      Park, Richardson & Patel

SecProbe.io